SKI Market

Indian Indices

Sensex

80,722.94 -1,546.84
( -1.88%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

63.93

160721.32

EPS(TTM)

Face Value()

Div & Yield %

94.7

0.49

Back

modern engineering & projects limited

Nalwa Sons Investments Ltd - Letter To Shareholders Pursuant To Regulation 36(1)(B) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

Sep 05,2025

Letter to shareholders pursuant to Regulation 36(1)(b) of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations 2015('SEBI Listing Regulations')

80,722.94 -1,546.84 ( -1.88%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)